EUVIMEDEUVIMED entdecken
Crossref

Plasma proteome-based integrated mendelian randomization and multi-omics analysis identifies potential diagnostic biomarkers and therapeutic targets for prostate cancer

Journal of Men's Health · 2026 · 22 (5) · 66

DOI: 10.22514/jomh.2026.042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Men's Health, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Plasma proteome-based integrated mendelian randomization and multi-omics analysis identifies potential diagnostic biomarkers and therapeutic targets for prostate cancer. Journal of Men's Health, 22(5), 66. https://doi.org/10.22514/jomh.2026.042

Vancouver

Plasma proteome-based integrated mendelian randomization and multi-omics analysis identifies potential diagnostic biomarkers and therapeutic targets for prostate cancer. Journal of Men's Health. 2026;22(5):66. doi:10.22514/jomh.2026.042

BibTeX
@article{euvimed2026,
  title = {Plasma proteome-based integrated mendelian randomization and multi-omics analysis identifies potential diagnostic biomarkers and therapeutic targets for prostate cancer},
  journal = {Journal of Men's Health},
  year = {2026},
  volume = {22},
  number = {5},
  pages = {66},
  doi = {10.22514/jomh.2026.042}
}
Kostenlos starten →